Azelastine hydrochloride
SIGMA/A7611 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 79307-93-0
Empirical Formula (Hill Notation): C22H24ClN3O · HCl
Molecular Weight: 418.36
MDL Number: MFCD00242783
Linear Formula: C22H24ClN3O · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C22H24ClN3O.ClH/c1-25- |
| InChI key | YEJAJYAHJQIWNU-UHFFFAOYSA |
| originator | Wallace |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CN1CCCC(CC1)N2N=C(Cc3c |
| solubility | DMSO: >10 mg/mL |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | Azelastine hydrochloride is a H1 histamine receptor antagonist and NF-kB activator. Azelastine hydrochloride has been used in a study to investigate the potential of polymeric microspheres for treatment of allergic conjunctivitis. |
| Biochem/physiol Actions: | H1 histamine receptor antagonist; NF-kB activator. |
| Features and Benefits: | This compound is featured on the Histamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Wallace . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264 - P270 - P301 + P312 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


